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Introduction
The integrity of the genome is continuously challenged by a variety of genotoxic agents, causing DNA lesions, which interfere with transcription (inducing premature cell death and ageing) and DNA replication (inducing mutations leading to cancer). To prevent the deleterious consequences of genomic insults, genome surveillance systems including DNA repair processes protect the genomic information. Nucleotide excision repair (NER) is one of the most important DNA repair systems and removes helix--distorting DNA--adducts in a complex multi--step reaction.
Disruption of NER in response to genotoxic injuries results in the rare genetic disorders ranging from the cancer--prone xeroderma pigmentosum (XP) phenotype to premature ageing Cockayne syndrome (CS) and Trichothiodystrophy (TTD) (1) .
In the NER pathway, the transcription factor TFIIH unwinds DNA and recruits other factors required to remove the damaged oligonucleotide. TFIIH is a 10 subunit protein complex (2) essential for RNA polymerase II (RNAP2) transcription initiation (3), RNA polymerase I (RNAP1) transcription (4) and NER (5) . The ten subunits cluster in two sub--complexes: the core complex composed of 7 tightly bound proteins (XPB, XPD, p62, p52, p44, p34 and TTDA) and the CAK (CDK--activating kinase) complex composed of the remaining 3 components (CDK7, Cyclin H and MAT1), repair (6) . However, despite a similar DNA repair defect, while XP patients are highly cancer prone, CS and TTD phenotypes are not associated with cancer predisposition. This discrepancy cannot simply be explained by a DNA repair defect and could be the result of the affected TFIIH transcriptional functions (7) . Besides the common DNA repair defect, a characteristic of TTD patients mutated in TFIIH subunits is the low cellular TFIIH steady state levels (2) , in contrast with the cancer--prone XP patients that have normal TFIIH levels. Importantly, it is nowadays acquired (mostly in cancer related research) that a bidirectional connection exists between cellular metabolism and gene transcription and that both are probably tightly coordinated (8) . The increased cellular metabolism needed for chronic unscheduled proliferation in cancer cells induces and depends on an increased transcriptional activity and in many cancers a dysregulation of the RNAP2 and RNAP1 transcription have been observed (9) . The importance of transcriptional activity during carcinogenesis is best highlighted by the fact that many molecules interfering with transcription have been used as chemotherapeutic drugs (10) and particularly two chemotherapeutic drugs, triptolide and spironolactone, interfere with TFIIH activity (11, 12) . On the basis of these observations, it has been hypothesised that reduced TFIIH levels could play a protective role by preventing chronic proliferation: a mandatory requirement during carcinogenesis (2) . In order to verify this hypothesis, a first step would be to demonstrate that TFIIH cellular concentration is indeed linked to transcriptional activity and cellular metabolism/proliferation. To verify this hypothesis, we analysed TFIIH steady state levels in a mouse model system in which the yellow fluorescent protein (YFP) was targeted to the last exon of the XPB gene (encoding for one of two helicase that constitute the core TFIIH complex, hereafter XPB--YFP) (13) . Homozygous XPB--YFP knock--in mice (Xpb y/y ) were born healthy, fertile and DNA repair efficient (13) and no features of premature ageing or increased spontaneous carcinogenesis were observed (13) . Our results show that TFIIH cellular concentration is strictly regulated in distinct cell types within the organism. Importantly, we could show that TFIIH steady state correlates with transcriptional activity and cellular proliferation and that cancerous tissues show increased TFIIH levels.
Results
Single cell quantification of TFIIH in organs from the Xpb y/y mouse model. We used a mouse model system in which the yellow fluorescent protein (YFP) was targeted to the last exon of the XPB gene (encoding for one of two helicase that constitute the core TFIIH complex, hereafter XPB--YFP) (13) . Homozygous XPB--YFP knock--in mice (Xpb y/y ) were born healthy, fertile and DNA repair efficient (13) and no features of premature ageing or increased spontaneous carcinogenesis were observed (13) . In order to map TFIIH levels in a living organism, direct measurements of the XPB--YFP fluorescence in both cryosections of organs and living organotypic tissue slices were undertaken, on our Xpb y/y mouse model, via 3D confocal microscopy. The choice of using organs and cells derived from the Xpb y/y mouse model and to directly measure the YFP fluorescent signal was made after having considered that as a core sub--unit of TFIIH, XPB is considered to exist in the nucleus only as part of TFIIH and this holds true for the fluorescently tagged XPB (14) . Importantly, the presence of the YFP fluorescent tag in fusion with XPB within TFIIH does not affect TFIIH steady state as shown in Figure S1 , demonstrating that our approach and model are both solid and that results can be suggests that the amount of TFIIH in cells could reflect specific neuronal transcriptional activity. To reliably assess whether or not TFIIH levels correlate with transcriptional activity, we first needed to develop a quantitative approach that allows more accurate measurements of the total amount of XPB--YFP per cell nucleus. To achieve this, we used a confocal laser--scanning microscope to acquire 3D image stacks of tissues and cultured cells derived from the Xpb y/y mouse model.
Typically, ex vivo tissue slices were maintained metabolically active during image acquisition under the microscope (13) . The resulting 3D image sets were processed via quantitative deconvolution in order to spatially reassigns "out--of--focus fluorescence" to the correct voxel coordinates. The total amount of TFIIH per cell was then estimated by integrating the XPB--YFP fluorescence signal within each fully imaged nucleus (cf. Fig. S2 and Methods). The results we obtained for several tissues (brain, intestine, kidney, liver, skin and spleen) are shown in Figure  1C , with the total fluorescence per nucleus plotted (in arbitrary units) versus the reconstructed volume occupied by the YFP signal of each analysed cell (in cubic micrometers).
By displaying our data in this manner, a linear relation between the total amount of TFIIH per cell and the nuclear volume is revealed. 
TFIIH levels correlate with transcriptional activity
A clear example suggesting a correlation between transcriptional activity and TFIIH levels was found when inspecting sections of testis, in particular the seminiferous tubules in which male germ cell development proceeds in a peripheral--to--central fashion. Indeed, during this process, chromatin in male germ cells is progressively condensed, concomitantly genes are silenced by promoter methylation and gradually basal transcription is reduced to undetectable levels (16--18) .
Immunohistochemistry of the seminiferous tubules of an Xpb y/y mouse showed that TFIIH concentration follows the peripheral--to--central reduction of transcriptional activity ( figure 2B (green dots), a linear correlation can be observed between the measured amount of mRNA produced and XPB steady--state levels. We could also measure the same correlation when cells were immuno--stained with an antibody against p62, another TFIIH core subunit ( Fig 2B, blue dots) , thus demonstrating that the total amount of cellular TFIIH is proportional to the cellular transcriptional activity. Interestingly, we could also measure the correlation between mRNA production and the basal transcription factor TBP (Tata--Binding Protein) (19) that is part of the TFIID complex, which also participate in RNAP2 transcription initiation, and we could also measure a correlation (although less proportional that the one observed for TFIIH) between the total amount of TBP and the transcriptional activity ( Fig 
TFIIH levels correlate with proliferation
Since TFIIH can provide a measure of transcriptional activity, we also wanted to determine if TFIIH can also be used as a marker for proliferation. To establish this, we modulated the proliferation status of cultured cells then measured changes in mRNA production and TFIIH steady--state levels. Modulation of proliferation was obtained in cultured primary chondrocytes (neither transformed nor immortalized) kept in low oxygen (3%) culture conditions. Serum starvation of confluent chondrocytes cultures will strongly stop proliferation, while dilution of these cultures in presence of a high level of serum will rapidly induce proliferation. Our measures of mRNA production and total TFIIH amounts show that in murine chondrocytes (Fig.  3A) isolated from the Xpb y/y mouse model, arrested cells present a low basal transcriptional activity and correspondingly low TFIIH amounts. On the contrary, the general mRNA production and the total cellular TFIIH amounts are higher in proliferative chondrocytes (Fig  3A) . We verified the results by Western Blot of the subunits XPB, p62, CDK7 and Cyclin H in both culture conditions (Serum--starved and Proliferation) (Fig 3B) . Because different TFIIH levels can be the result of an increased transcriptional activity hence an increased protein production, we loaded the same number of cells per well (500.000). A clear increase of core and CAK subunits of TFIIH have been observed in the proliferative cells compared to the serum--starved. Indeed, when the TFIIH level of serum--starved cells was normalised to 1, an increase of 50 to 80 % was measured in proliferative cells (Fig 3C) .
TFIIH levels in colorectal cancer
In order to investigate whether TFIIH levels are also increased in cancer tissues, we stained a tissue section of a human colorectal cancer including adjacent normal colon tissue with an antibody against the XPB subunit of TFIIH and the proliferation marker Ki67 (Fig. 4) . The expression patterns in both tumor and non--tumor tissues were evaluated by the pathologist of this study. We found that XPB and Ki67 were concomitantly highly overexpressed in primary colon cancer tissue where both XPB and Ki67 were only minimally detected. Interestingly, in normal adjacent colon tissue, we observed a few cells with high levels of XPB correlated with Ki67 expression (Fig.  4C ), in the deeper regions of colonic crypts, where proliferating cells are expected. A consecutive serial section was also stained with hematoxylin to evaluate the morphology of the tissue (Fig. 4D, 4E ).
Discussion
To maintain the chronic proliferative state, cancer cells need a high rate of active transcription by the three RNA polymerases. RNAP1 and RNAP2 have been found dysregulated in many cancer models. Enhanced RNAP1 activity triggers nucleoli enlargement and it is considered a marker of aggressive cancer cells associated with a poor prognosis (20) . Enhanced RNAP2 activity has been found in many malignancies and many general transcription factors have been found consistently overexpressed in tumours (9) . One striking example is the TBP protein, which has been found overexpressed in colon (21) Methods.
Organotypic cultures.
Organotypic explants of living tissues were produced as previously described (33, 34 
Microscopy, image processing and analysis.
All microscopy work was performed on a Zeiss 780 confocal, except for the data shown in 
SDS--PAGE.
Proteins were separated using SDS--PAGE gel composed of bisacrylamide (37: 
